down arrow

Natco Pharma

47
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
767.90
21.05 (2.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.33 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
3,998.00
2,707.00
1,944.00
2,052.00
1,915.00
2,094.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
3,998.00
2,707.00
1,944.00
2,052.00
1,915.00
2,094.00
Expenditure (Ex Depriciation)
Stock Adjustments
42.00
-23.00
-16.00
-48.00
-75.00
-33.00
Raw Materials Consumed
673.00
651.00
577.00
559.00
456.00
388.00
Power & Fuel Cost
88.00
81.00
76.00
61.00
62.00
59.00
Employee Cost
525.00
486.00
444.00
414.00
375.00
355.00
Operating Expenses
174.00
142.00
140.00
107.00
126.00
112.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
153.00
96.00
43.00
34.00
98.00
90.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
131.00
35.00
81.00
43.00
66.00
58.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,247.00
1,771.00
1,681.00
1,445.00
1,332.00
1,299.00
Operating Profit (PBDIT) excl Other Income
1,751.00
935.00
263.00
606.00
582.00
794.00
Other Income
128.00
104.00
99.00
103.00
107.00
130.00
Operating Profit (PBDIT)
1,879.00
1,040.00
362.00
709.00
690.00
925.00
Interest
19.00
14.00
17.00
13.00
21.00
19.00
Profit before Depriciation and Tax
1,860.00
1,025.00
344.00
696.00
668.00
905.00
Depreciation
186.00
163.00
142.00
116.00
99.00
81.00
Profit Before Taxation & Exceptional Items
1,673.00
861.00
202.00
579.00
568.00
824.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,673.00
861.00
202.00
579.00
568.00
824.00
Provision for Tax
285.00
146.00
32.00
137.00
110.00
182.00
Profit After Tax
1,388.00
715.00
170.00
442.00
458.00
642.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
3,292.00
2,666.00
2,568.00
2,239.00
1,937.00
1,412.00
Profit Available for appropriations
4,680.00
3,381.00
2,738.00
2,680.00
2,397.00
2,056.00
Appropriations
4,680.00
3,381.00
2,738.00
2,680.00
2,397.00
2,056.00
Equity Dividend (%)
475.00%
275.00%
225.00%
262.50%
337.50%
312.50%
Earnings Per Share
77.34
39.18
9.32
24.20
25.33
34.98
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 47.72% vs 39.20% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 87.20% vs 255.07% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 32.41% vs -18.08% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 94.09% vs 320.76% in Mar 2023

Compare Profit and Loss Results of Natco Pharma
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
3,998.00
10,334.00
-6,336.00
-61.31%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
3,998.00
10,334.00
-6,336.00
-61.31%
Expenditure (Ex Depriciation)
Stock Adjustments
42.00
-94.00
136.00
144.68%
Raw Materials Consumed
673.00
3,263.00
-2,590.00
-79.37%
Power & Fuel Cost
88.00
129.00
-41.00
-31.78%
Employee Cost
525.00
2,274.00
-1,749.00
-76.91%
Operating Expenses
174.00
210.00
-36.00
-17.14%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
153.00
928.00
-775.00
-83.51%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
131.00
134.00
-3.00
-2.24%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,247.00
7,798.00
-5,551.00
-71.18%
Operating Profit (PBDIT) excl Other Income
1,751.00
2,536.00
-785.00
-30.95%
Other Income
128.00
280.00
-152.00
-54.29%
Operating Profit (PBDIT)
1,879.00
2,817.00
-938.00
-33.30%
Interest
19.00
35.00
-16.00
-45.71%
Profit before Depriciation and Tax
1,860.00
2,782.00
-922.00
-33.14%
Depreciation
186.00
398.00
-212.00
-53.27%
Profit Before Taxation & Exceptional Items
1,673.00
2,384.00
-711.00
-29.82%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,673.00
2,399.00
-726.00
-30.26%
Provision for Tax
285.00
457.00
-172.00
-37.64%
Profit After Tax
1,388.00
1,926.00
-538.00
-27.93%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
3,292.00
8,012.00
-4,720.00
-58.91%
Profit Available for appropriations
4,680.00
9,925.00
-5,245.00
-52.85%
Appropriations
4,680.00
9,925.00
-5,245.00
-52.85%
Equity Dividend (%)
475%
0%
475.00
Earnings Per Share
77.34
47.75
29.59
61.97%
Profit And Loss - Net Sales
Net Sales 3,998.80 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 47.72% vs 39.20% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,751.40 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 87.20% vs 255.07% in Mar 2023

Profit And Loss - Interest
Interest 19.20 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 32.41% vs -18.08% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 1,388.30 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 94.09% vs 320.76% in Mar 2023